Janssen Robert 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Common Stock
2025-02-10+4,333→ 63,017 total - Exercise/Conversion
Restricted Stock Unit
2025-02-10−4,333→ 0 total→ Common Stock (4,333 underlying) - Tax Payment
Common Stock
2025-02-10$13.20/sh−1,781$23,509→ 61,236 total
Footnotes (2)
- [F1]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
- [F2]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.